Skip to main navigation
Skip to search
Skip to main content
Amsterdam UMC Home
Help & FAQ
Link opens in a new tab
Search content at Amsterdam UMC
Home
Researchers
Departments & Research Institutes
Projects & Funding
Publications
Datasets
Prizes
Activities
Courses
Cohorts
Press/Media
Impact
Germline genetic biomarker to predict metastatic risk in melanoma patients.
Ouwerkerk, Wouter
(Recipient)
Epidemiology and Data Science
CCA - Cancer Treatment and quality of life
CCA - Imaging and biomarkers
CCA - Cancer biology and immunology
Dermatology
Prize
›
Academic
Description
This project aims to develop a germline genetic biomarker to predict the metastatic potential of early-stage melanoma patients
Awarded date
28 Nov 2023
Degree of recognition
National
Granting Organisations
Cancer Center Amsterdam
Fingerprint
Epigenetic Biomarkers
100%
Melanoma Patients
100%
Germline Genetics
100%
Metastatic Risk
100%
Germline
100%
Germ Cell
100%
Metastatic Potential
50%
X